CoreCap Advisors’s Avanos Medical AVNS Stock Holding History

CoreCap Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10	Closed	-$249	–	3161
2026 Q2	$249	Sell	10 -10	-50%	-$234	﹤0.01%	2981
2026 Q1	$280	Hold	20	–	–	﹤0.01%	2725
2025 Q4	$225	Hold	20	–	–	﹤0.01%	2803
2025 Q3	$231	Hold	20	–	–	﹤0.01%	2658
2025 Q2	$245	Hold	20	–	–	﹤0.01%	2601
2025 Q1	$287	Hold	20	–	–	﹤0.01%	2822
2024 Q4	$318	Hold	20	–	–	﹤0.01%	2620
2024 Q3	$481	Hold	20	–	–	﹤0.01%	2371
2024 Q2	$398	Hold	20	–	–	﹤0.01%	1464
2024 Q1	$398	Buy	+20	New	+$387	﹤0.01%	2355
2022 Q4	$541	Buy	+20	New	+$489	﹤0.01%	2153
2022 Q3	–	Sell	-20	Closed	-$1K	–	648
2022 Q2	$1K	Buy	+20	New	+$575	﹤0.01%	1949
2022 Q1	–	Sell	-25	Closed	-$1K	–	657
2021 Q4	$1K	Buy	+25	New	+$808	﹤0.01%	2047

Other funds holding AVNS

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Bayban Bayport, Minnesota $130M AUM 21.7% 1-Year Est. Return

CoreCap Advisors's AVNS Position: Q3 2026 in Review

CoreCap Advisors sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 10 shares — an estimated $249 sold.

CoreCap Advisors first reported a position in AVNS in Q4 2021 and held it in 13 quarters. The position peaked at $1K in Q2 2022. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

CoreCap Advisors reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
CoreCap Advisors sold 10 Avanos Medical shares in Q3 2026, an estimated $249.
CoreCap Advisors first reported a position in Avanos Medical in Q4 2021 and held it in 13 quarters.
CoreCap Advisors's Avanos Medical position peaked at $1K in Q2 2022.
3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.